Header Logo

A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neck.

A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res. 2012 Apr 15; 18(8):2336-43.

View in: PubMed